XML 31 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A Common Stock
Class B Common Stock
Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-in Capital
(Accumulated Deficit) Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning Balance (in shares) at Jan. 29, 2022         23,719,000 7,306,000      
Beginning Balance at Jan. 29, 2022 $ 174,713     $ 31     $ 166,929 $ 7,754 $ (1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 9,677             9,677  
Stock-based compensation expense 2,267           2,267    
Restricted stock (in shares)         63,000        
Exercise of stock options (in shares)         38,000        
Exercise of stock options 176     0     176    
Short swing profits disgorgement payment 661           661    
Repurchase of common stock (in shares)   (1,258,330)     (1,258,000)        
Repurchase of common stock (10,902) $ (10,900)   (1)       (10,901)  
Net change in unrealized gain on available-for-sale securities 206               206
Ending Balance (in shares) at Jan. 28, 2023         22,562,000 7,306,000      
Ending Balance at Jan. 28, 2023 176,798     30     170,033 6,530 205
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (34,492)             (34,492)  
Stock-based compensation expense 2,218           2,218    
Restricted stock (in shares)         57,000        
Exercise of stock options (in shares)         95,000        
Exercise of stock options 400           400    
Short swing profits disgorgement payment (173)           (173)    
Net change in unrealized gain on available-for-sale securities 118               118
Ending Balance (in shares) at Feb. 03, 2024   22,714,000 7,306,000   22,714,000 7,306,000      
Ending Balance at Feb. 03, 2024 144,869     30     172,478 (27,962) 323
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (46,229)             (46,229)  
Stock-based compensation expense $ 2,057           2,057    
Restricted stock (in shares)         61,000        
Exercise of stock options (in shares) 71,066       71,000        
Exercise of stock options $ 294           294    
Net change in unrealized gain on available-for-sale securities (120)               (120)
Ending Balance (in shares) at Feb. 01, 2025   22,846,000 7,306,000   22,846,000 7,306,000      
Ending Balance at Feb. 01, 2025 $ 100,871     $ 30     $ 174,829 $ (74,191) $ 203